143 related articles for article (PubMed ID: 28814986)
21. Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.
Philips KB; Kurtoglu M; Leung HJ; Liu H; Gao N; Lehrman MA; Murray TG; Lampidis TJ
Cancer Chemother Pharmacol; 2014 Feb; 73(2):349-61. PubMed ID: 24292700
[TBL] [Abstract][Full Text] [Related]
22. Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms.
Laussel C; Léon S
Biochem Pharmacol; 2020 Dec; 182():114213. PubMed ID: 32890467
[TBL] [Abstract][Full Text] [Related]
23. Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia.
Boag JM; Beesley AH; Firth MJ; Freitas JR; Ford J; Hoffmann K; Cummings AJ; de Klerk NH; Kees UR
Leukemia; 2006 Oct; 20(10):1731-7. PubMed ID: 17041637
[TBL] [Abstract][Full Text] [Related]
24. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy.
Zhang D; Li J; Wang F; Hu J; Wang S; Sun Y
Cancer Lett; 2014 Dec; 355(2):176-83. PubMed ID: 25218591
[TBL] [Abstract][Full Text] [Related]
25. Combining 2-deoxy-D-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress.
Liu H; Kurtoglu M; León-Annicchiarico CL; Munoz-Pinedo C; Barredo J; Leclerc G; Merchan J; Liu X; Lampidis TJ
Oncotarget; 2016 Jun; 7(24):36461-36473. PubMed ID: 27183907
[TBL] [Abstract][Full Text] [Related]
26. The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance.
Ariës IM; Hansen BR; Koch T; van den Dungen R; Evans WE; Pieters R; den Boer ML
Haematologica; 2013 Dec; 98(12):1905-11. PubMed ID: 24142999
[TBL] [Abstract][Full Text] [Related]
27. Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance.
Bonapace L; Bornhauser BC; Schmitz M; Cario G; Ziegler U; Niggli FK; Schäfer BW; Schrappe M; Stanulla M; Bourquin JP
J Clin Invest; 2010 Apr; 120(4):1310-23. PubMed ID: 20200450
[TBL] [Abstract][Full Text] [Related]
28. [Effect of glucocorticoid on the expression of Puma in acute lymphoblastic leukemia].
Xu B; Wang BJ; Li AM; Lock R
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):151-4. PubMed ID: 16613713
[TBL] [Abstract][Full Text] [Related]
29. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract][Full Text] [Related]
30. Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor-B cell acute lymphoblastic leukemia.
Sweeney SR; Collins M; Pandey R; Chiou J; Lodi A; Tiziani S
Mol Carcinog; 2020 Apr; 59(4):399-411. PubMed ID: 32027051
[TBL] [Abstract][Full Text] [Related]
31. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
[TBL] [Abstract][Full Text] [Related]
32. Non-thermal plasma with 2-deoxy-D-glucose synergistically induces cell death by targeting glycolysis in blood cancer cells.
Kaushik N; Lee SJ; Choi TG; Baik KY; Uhm HS; Kim CH; Kaushik NK; Choi EH
Sci Rep; 2015 Mar; 5():8726. PubMed ID: 25735798
[TBL] [Abstract][Full Text] [Related]
33. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
Wokoun U; Hellriegel M; Emons G; Gründker C
Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
35. Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment.
Dyczynski M; Vesterlund M; Björklund AC; Zachariadis V; Janssen J; Gallart-Ayala H; Daskalaki E; Wheelock CE; Lehtiö J; Grandér D; Tamm KP; Nilsson R
Cell Death Dis; 2018 Aug; 9(9):846. PubMed ID: 30154400
[TBL] [Abstract][Full Text] [Related]
36. Nerve growth factor attenuates 2-deoxy-d-glucose-triggered endoplasmic reticulum stress-mediated apoptosis via enhanced expression of GRP78.
Kishi S; Shimoke K; Nakatani Y; Shimada T; Okumura N; Nagai K; Shin-Ya K; Ikeuchi T
Neurosci Res; 2010 Jan; 66(1):14-21. PubMed ID: 19766678
[TBL] [Abstract][Full Text] [Related]
37. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
38. APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells.
Cagnetta A; Caffa I; Acharya C; Soncini D; Acharya P; Adamia S; Pierri I; Bergamaschi M; Garuti A; Fraternali G; Mastracci L; Provenzani A; Zucal C; Damonte G; Salis A; Montecucco F; Patrone F; Ballestrero A; Bruzzone S; Gobbi M; Nencioni A; Cea M
Clin Cancer Res; 2015 Sep; 21(17):3934-45. PubMed ID: 25964294
[TBL] [Abstract][Full Text] [Related]
39. Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes.
Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T
Anticancer Res; 2017 Jan; 37(1):149-159. PubMed ID: 28011485
[TBL] [Abstract][Full Text] [Related]
40. Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.
Iacovelli S; Ricciardi MR; Allegretti M; Mirabilii S; Licchetta R; Bergamo P; Rinaldo C; Zeuner A; Foà R; Milella M; McCubrey JA; Martelli AM; Tafuri A
Oncotarget; 2015 Oct; 6(31):32089-103. PubMed ID: 26392332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
